The Faculty has a strong record of forming start-up companies, for example in using innovative cell and gene therapies against genetic diseases and cancer. We work with UCLB - the commercialisation company of UCL and its partner NHS Trusts to develop, launch and support start-up companies. We bring to market truly world-leading, world-changing technologies, innovations that have a real and positive impact on people's lives.
Orchard Therapeutics, a UCL spinout, is using stell cell gene therapy developed by academics to transform the lives of children with severe genetic conditions.
Close
